A detailed history of Srs Capital Advisors, Inc. transactions in Natera, Inc. stock. As of the latest transaction made, Srs Capital Advisors, Inc. holds 1 shares of NTRA stock, worth $171. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1
Previous 22 95.45%
Holding current value
$171
Previous $3,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025

SELL
$132.63 - $177.0 $2,785 - $3,717
-21 Reduced 95.45%
1 $0
Q4 2024

Feb 05, 2025

SELL
$117.67 - $174.0 $81,545 - $120,582
-693 Reduced 96.92%
22 $3,000
Q2 2024

Aug 06, 2024

BUY
$85.28 - $112.6 $60,975 - $80,509
715 New
715 $77,000

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $16.7B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Srs Capital Advisors, Inc. Portfolio

Follow Srs Capital Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Srs Capital Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Srs Capital Advisors, Inc. with notifications on news.